|1||NCT00595322||Completed||Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma||
||Other / Industry||
||25||All||18 Years and older (Adult, Senior)||NCT00595322||05-092||December 2005||May 2017||May 2017||January 16, 2008||May 23, 2017||
|2||NCT01308034||Active, not recruiting||Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy||
||18||All||18 Years and older (Adult, Senior)||NCT01308034||RT - SUTENT
|March 2011||May 2016||April 2018||March 3, 2011||September 26, 2017||
† Study has passed its completion date and status has not been verified in more than two years.